Here we found that inhibition of ERK1/2 and AKT by PD98059 and LY294002, respectively, enhanced the effect of RSL3 on decreasing the viability of RCC cells as well as lipid peroxidation and MDA production. This evidence concerns the gene MAPK3 and renal cell carcinoma.